DrugPatentWatch Database Preview
Upadacitinib - Generic Drug Details
What are the generic drug sources for upadacitinib and what is the scope of patent protection?
Upadacitinib
is the generic ingredient in one branded drug marketed by Abbvie Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for upadacitinib
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 24 |
| Clinical Trials: | 20 |
| Patent Applications: | 30 |
| DailyMed Link: | upadacitinib at DailyMed |
Recent Clinical Trials for upadacitinib
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| AbbVie | Phase 1 |
| AbbVie | Phase 2 |
| AbbVie | Phase 3 |
Synonyms for upadacitinib
| (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide |
| (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide |
| 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)- |
| 1310726-59-0 |
| 1310726-60-3 |
| 4RA0KN46E0 |
| ABT 494 |
| ABT-494 |
| ABT-494 enantiomer |
| ABT494 |
| AC-30326 |
| BCP19011 |
| CHEMBL3622821 |
| CS-6150 |
| D10994 |
| EX-A1628 |
| GTPL9246 |
| HY-19569 |
| J3.590.729G |
| MFCD30502663 |
| Rinvoq |
| SB19218 |
| SCHEMBL9991056 |
| UNII-4RA0KN46E0 |
| Upadacitinib (USAN/INN) |
| Upadacitinib [USAN:INN] |
| Upadacitinib, ABT-494 |
US Patents and Regulatory Information for upadacitinib
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | RINVOQ | upadacitinib | TABLET, EXTENDED RELEASE;ORAL | 211675-001 | Aug 16, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
